
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Pulmonary Arterial Hypertension Patients Have a Proinflammatory Gut Microbiome and Altered Circulating Microbial Metabolites
Daphne Moutsoglou, Jasmine Tatah, Sasha Z. Prisco, et al.
American Journal of Respiratory and Critical Care Medicine (2022) Vol. 207, Iss. 6, pp. 740-756
Open Access | Times Cited: 39
Daphne Moutsoglou, Jasmine Tatah, Sasha Z. Prisco, et al.
American Journal of Respiratory and Critical Care Medicine (2022) Vol. 207, Iss. 6, pp. 740-756
Open Access | Times Cited: 39
Showing 1-25 of 39 citing articles:
Distinct airway mycobiome signature in patients with pulmonary hypertension and subgroups
Chenting Zhang, Bihua Zhong, Jiang Qian, et al.
BMC Medicine (2025) Vol. 23, Iss. 1
Open Access | Times Cited: 1
Chenting Zhang, Bihua Zhong, Jiang Qian, et al.
BMC Medicine (2025) Vol. 23, Iss. 1
Open Access | Times Cited: 1
Gut microbiota-derived acetate attenuates lung injury induced by influenza infection via protecting airway tight junctions
Lei Hu, Li Sun, Chun Yang, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 10
Lei Hu, Li Sun, Chun Yang, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 10
Gut Microbiota and Microbial Metabolism in Early Risk of Cardiometabolic Disease
Curtis L. Gabriel, Jane F. Ferguson
Circulation Research (2023) Vol. 132, Iss. 12, pp. 1674-1691
Open Access | Times Cited: 19
Curtis L. Gabriel, Jane F. Ferguson
Circulation Research (2023) Vol. 132, Iss. 12, pp. 1674-1691
Open Access | Times Cited: 19
Promising dawn in the management of pulmonary hypertension: The mystery veil of gut microbiota
Yicheng Yang, Hanwen Zhang, Yaoyao Wang, et al.
iMeta (2024) Vol. 3, Iss. 2
Open Access | Times Cited: 6
Yicheng Yang, Hanwen Zhang, Yaoyao Wang, et al.
iMeta (2024) Vol. 3, Iss. 2
Open Access | Times Cited: 6
Precision Medicine for Pulmonary Vascular Disease: The Future Is Now (2023 Grover Conference Series)
Lindsay M. Forbes, Natalie Bauer, Aritra Bhadra, et al.
Pulmonary Circulation (2025) Vol. 15, Iss. 1
Open Access
Lindsay M. Forbes, Natalie Bauer, Aritra Bhadra, et al.
Pulmonary Circulation (2025) Vol. 15, Iss. 1
Open Access
The fungal microbiota modulate neonatal oxygen-induced lung injury
Isaac Martin, Mary Silverberg, Ahmed Abdelgawad, et al.
Microbiome (2025) Vol. 13, Iss. 1
Open Access
Isaac Martin, Mary Silverberg, Ahmed Abdelgawad, et al.
Microbiome (2025) Vol. 13, Iss. 1
Open Access
Exploring the Causal Relationship Between Gut Microbiota and Pulmonary Artery Hypertension: Insights From Mendelian Randomization
Lihuang Su, Xinghong Wang, Ya Lin, et al.
Journal of the American Heart Association (2025)
Open Access
Lihuang Su, Xinghong Wang, Ya Lin, et al.
Journal of the American Heart Association (2025)
Open Access
Assessing causal relationships between gut microbiotas, metabolites, and pulmonary arterial hypertension through univariate Mendelian randomization study and bioinformatics analysis
Dongrui Xu, Hong Liu, Jiankang Yang
Journal of Hypertension (2025)
Closed Access
Dongrui Xu, Hong Liu, Jiankang Yang
Journal of Hypertension (2025)
Closed Access
Causal effects between gut microbiota and pulmonary arterial hypertension: A bidirectional Mendelian randomization study
Chenwei Zhang, Yujia Xi, Yukai Zhang, et al.
Heart & Lung (2024) Vol. 64, pp. 189-197
Closed Access | Times Cited: 3
Chenwei Zhang, Yujia Xi, Yukai Zhang, et al.
Heart & Lung (2024) Vol. 64, pp. 189-197
Closed Access | Times Cited: 3
Schistosomiasis-associated pulmonary hypertension unveils disrupted murine gut–lung microbiome and reduced endoprotective Caveolin-1/BMPR2 expression
Ygor Marinho, Elizabeth S. Villarreal, Samuel Yaw Aboagye, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 7
Ygor Marinho, Elizabeth S. Villarreal, Samuel Yaw Aboagye, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 7
Alveolar macrophage modulation via the gut–lung axis in lung diseases
Zijian Chen, Yangqi Liu, Weizhe Huang
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 7
Zijian Chen, Yangqi Liu, Weizhe Huang
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 7
Exploring a novel therapeutic strategy: the interplay between gut microbiota and high-fat diet in the pathogenesis of metabolic disorders
Xiaokang Jia, Qiliang Chen, Hui‐Wen Wu, et al.
Frontiers in Nutrition (2023) Vol. 10
Open Access | Times Cited: 7
Xiaokang Jia, Qiliang Chen, Hui‐Wen Wu, et al.
Frontiers in Nutrition (2023) Vol. 10
Open Access | Times Cited: 7
Pulmonary Hypertension and the Gut Microbiome
Thomas Mason, Bhashkar Mukherjee, Philip Marino
Biomedicines (2024) Vol. 12, Iss. 1, pp. 169-169
Open Access | Times Cited: 1
Thomas Mason, Bhashkar Mukherjee, Philip Marino
Biomedicines (2024) Vol. 12, Iss. 1, pp. 169-169
Open Access | Times Cited: 1
Periodontitis exacerbates pulmonary hypertension by promoting IFNγ+ T cell infiltration in mice
Xiao-Qian Meng, Lin‐Juan Du, Shuo Xu, et al.
International Journal of Oral Science (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 1
Xiao-Qian Meng, Lin‐Juan Du, Shuo Xu, et al.
International Journal of Oral Science (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 1
A peripheral system disease—Pulmonary hypertension
Yang Sun, Chen Chen, Yan Qian, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 175, pp. 116787-116787
Open Access | Times Cited: 1
Yang Sun, Chen Chen, Yan Qian, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 175, pp. 116787-116787
Open Access | Times Cited: 1
Disease-associated gut microbiome and metabolome changes in rats with chronic hypoxia-induced pulmonary hypertension
Weitao Cao, Luyao Wang, Qiudi Mo, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 1
Weitao Cao, Luyao Wang, Qiudi Mo, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 1
Effects of the ACE2-Ang-(1-7)-Mas axis on gut flora diversity and intestinal metabolites in SuHx mice
Asimuguli Abudukeremu, Ainiwaer Aikemu, Tao Yang, et al.
Frontiers in Microbiology (2024) Vol. 15
Open Access | Times Cited: 1
Asimuguli Abudukeremu, Ainiwaer Aikemu, Tao Yang, et al.
Frontiers in Microbiology (2024) Vol. 15
Open Access | Times Cited: 1
LactobacillusRestructures the Micro/Mycobiome to Combat Glycoprotein-130 Associated Microtubule Remodeling and Right Ventricular Dysfunction in Pulmonary Arterial Hypertension
Sasha Z. Prisco, Madelyn Blake, Felipe Kazmirczak, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Sasha Z. Prisco, Madelyn Blake, Felipe Kazmirczak, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Causal relationships between gut microbiota, plasma metabolites, and HIV infection: insights from Mendelian randomization and mediation analysis
Jiapeng Hu, Jinxin Hu, Dan Han
Virology Journal (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 1
Jiapeng Hu, Jinxin Hu, Dan Han
Virology Journal (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 1
Gut microbiome alterations in pulmonary hypertension in highlanders and lowlanders
Wenxue Dong, Lifeng Ma, Qiumin Huang, et al.
ERJ Open Research (2023) Vol. 9, Iss. 3, pp. 00617-2022
Open Access | Times Cited: 3
Wenxue Dong, Lifeng Ma, Qiumin Huang, et al.
ERJ Open Research (2023) Vol. 9, Iss. 3, pp. 00617-2022
Open Access | Times Cited: 3
The fungal intestinal microbiota predict the development of bronchopulmonary dysplasia in very low birthweight newborns
Kent A. Willis, Mary Silverberg, Isaac Martin, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 3
Kent A. Willis, Mary Silverberg, Isaac Martin, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 3
High-Soluble-Fiber Diet Attenuates Hypoxia-Induced Vascular Remodeling and the Development of Hypoxic Pulmonary Hypertension
Nikolai V. Pakhomov, Daria S. Kostyunina, Guerrino Macori, et al.
Hypertension (2023) Vol. 80, Iss. 11, pp. 2372-2385
Closed Access | Times Cited: 3
Nikolai V. Pakhomov, Daria S. Kostyunina, Guerrino Macori, et al.
Hypertension (2023) Vol. 80, Iss. 11, pp. 2372-2385
Closed Access | Times Cited: 3
Cardiopulmonary Pathogenic Networks: Unveiling the Gut–Lung Microbiome Axis in Pulmonary Arterial Hypertension
Suellen Darc Oliveira
American Journal of Respiratory and Critical Care Medicine (2022) Vol. 207, Iss. 6, pp. 655-657
Open Access | Times Cited: 4
Suellen Darc Oliveira
American Journal of Respiratory and Critical Care Medicine (2022) Vol. 207, Iss. 6, pp. 655-657
Open Access | Times Cited: 4
Gut microbiota crosstalk mechanisms are key in pulmonary hypertension: The involvement of melatonin is instrumental too
Steve Jacobs, Carmen Payne, S Shaboodien, et al.
Pulmonary Circulation (2023) Vol. 13, Iss. 3
Open Access | Times Cited: 2
Steve Jacobs, Carmen Payne, S Shaboodien, et al.
Pulmonary Circulation (2023) Vol. 13, Iss. 3
Open Access | Times Cited: 2
Microbiota and pulmonary hypertension: a systematic review on human studies
Hossein Yarmohammadi, Masood Soltanipur, Mahdi Rezaei, et al.
Research Square (Research Square) (2024)
Open Access
Hossein Yarmohammadi, Masood Soltanipur, Mahdi Rezaei, et al.
Research Square (Research Square) (2024)
Open Access